BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 33148289)

  • 1. The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands.
    Dinmohamed AG; Cellamare M; Visser O; de Munck L; Elferink MAG; Westenend PJ; Wesseling J; Broeders MJM; Kuipers EJ; Merkx MAW; Nagtegaal ID; Siesling S
    J Hematol Oncol; 2020 Nov; 13(1):147. PubMed ID: 33148289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study.
    de Jonge L; Worthington J; van Wifferen F; Iragorri N; Peterse EFP; Lew JB; Greuter MJE; Smith HA; Feletto E; Yong JHE; Canfell K; Coupé VMH; Lansdorp-Vogelaar I;
    Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):304-314. PubMed ID: 33548185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
    Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway: A population-based study.
    Eijkelboom AH; de Munck L; Larsen M; Bijlsma MJ; Tjan-Heijnen VCG; van Gils CH; Broeders MJM; Nygård JF; Lobbes MBI; Helsper CW; Pijnappel RM; Strobbe LJA; Wesseling J; Hofvind S; Siesling S;
    Cancer Epidemiol; 2023 Dec; 87():102481. PubMed ID: 37897970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the COVID-19 Pandemic on Surgical Breast Cancer Care in the Netherlands: A Multicenter Retrospective Cohort Study.
    Filipe MD; van Deukeren D; Kip M; Doeksen A; Pronk A; Verheijen PM; Heikens JT; Witkamp AJ; Richir MC
    Clin Breast Cancer; 2020 Dec; 20(6):454-461. PubMed ID: 32888855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Le disuguaglianze di accesso ai programmi di screening dei tumori della mammella, del colon retto e della cervice uterina sono aumentate durante il periodo pandemico. Risultati di un health equity audit condotto dall'Agenzia di Tutela della Salute d.
    Girardi D; Vecchio R; Tanious M; Cacitti S; Ancarani C; Dalle Carbonare S; Perotti P; Bonafede C; Cavallo R; Gentile L; Parrini A; Lucente EM; Carlesso A; Cadum E; Cecconami L; Odone A; Deandrea S
    Epidemiol Prev; 2024; 48(2):130-139. PubMed ID: 38770730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of predictive factors for non-adherence to organized screening for colorectal and breast cancers in the pre-pandemic period (2018-2019) in Lombardy Region (Northern Italy)].
    Russo AG; Murtas R; Ballotari P; Cavalieri d'Oro L; Gambino ML; Fanetti AC; Maifredi G; Manzoni F; Sampietro G; Leoni O; Celata C; Cereda D; Deandrea S;
    Epidemiol Prev; 2024; 48(2):118-129. PubMed ID: 38770729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada.
    Yong JH; Mainprize JG; Yaffe MJ; Ruan Y; Poirier AE; Coldman A; Nadeau C; Iragorri N; Hilsden RJ; Brenner DR
    J Med Screen; 2021 Jun; 28(2):100-107. PubMed ID: 33241760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast Cancer Screening During the COVID-19 Pandemic in the United States: Results From Real-World Health Records Data.
    Chung A; Chen Q; Curry W; Felix T; Tuan WJ
    Ann Fam Med; 2024; 22(3):208-214. PubMed ID: 38806260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model-Based Estimation of Colorectal Cancer Screening and Outcomes During the COVID-19 Pandemic.
    Issaka RB; Taylor P; Baxi A; Inadomi JM; Ramsey SD; Roth J
    JAMA Netw Open; 2021 Apr; 4(4):e216454. PubMed ID: 33843997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invitation coverage and participation in Italian cervical, breast and colorectal cancer screening programmes.
    Giorgi Rossi P; Carrozzi G; Federici A; Mancuso P; Sampaolo L; Zappa M
    J Med Screen; 2018 Mar; 25(1):17-23. PubMed ID: 28614991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invitation strategies and coverage in the population-based cancer screening programmes in the European Union.
    Vale DB; Anttila A; Ponti A; Senore C; Sankaranaryanan R; Ronco G; Segnan N; Tomatis M; Žakelj MP; Elfström KM; Lönnberg S; Dillner J; Basu P
    Eur J Cancer Prev; 2019 Mar; 28(2):131-140. PubMed ID: 29570103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study.
    Morris EJA; Goldacre R; Spata E; Mafham M; Finan PJ; Shelton J; Richards M; Spencer K; Emberson J; Hollings S; Curnow P; Gair D; Sebag-Montefiore D; Cunningham C; Rutter MD; Nicholson BD; Rashbass J; Landray M; Collins R; Casadei B; Baigent C
    Lancet Gastroenterol Hepatol; 2021 Mar; 6(3):199-208. PubMed ID: 33453763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective.
    Tsibulak I; Reiser E; Bogner G; Petru E; Hell-Teutsch J; Reinthaller A; Weirather C; Weiss T; Bozsa S; Puschacher B; Hall M; Hittler D; Hrauda K; Thell E; Clauss S; Pozniak J; Alicke S; Gangl D; Gamperl G; Ebner C; Knoll K; Leitner K; Schilcher A; Schinnerl M; Sigl V; Singer C; Aigmüller T; Hofstätter B; Marth C
    Int J Gynecol Cancer; 2020 Nov; 30(11):1667-1671. PubMed ID: 33033166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Responsible cancer screening].
    Verbeek AL; van Dijck JA; Kiemeney LA; Broeders MJ
    Ned Tijdschr Geneeskd; 2011; 155(45):A3934. PubMed ID: 22085573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dutch digital breast cancer screening: implications for breast cancer care.
    Timmers JM; den Heeten GJ; Adang EM; Otten JD; Verbeek AL; Broeders MJ
    Eur J Public Health; 2012 Dec; 22(6):925-9. PubMed ID: 22158996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario.
    Vanni G; Pellicciaro M; Materazzo M; Bruno V; Oldani C; Pistolese CA; Buonomo C; Caspi J; Gualtieri P; Chiaravalloti A; Palombi L; Piccione E; Buonomo OC
    In Vivo; 2020; 34(5):3047-3053. PubMed ID: 32871851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptions and beliefs of general practitioners on their role in the cancer screening programmes in the Netherlands: a mixed-methods study.
    Bongaerts THG; Büchner FL; Nierkens V; Crone MR; Guicherit OR; Numans ME
    BMC Prim Care; 2024 Apr; 25(1):129. PubMed ID: 38658815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of (non-)attendance at the Dutch cancer screening programmes: A systematic review.
    Bongaerts TH; Büchner FL; Middelkoop BJ; Guicherit OR; Numans ME
    J Med Screen; 2020 Sep; 27(3):121-129. PubMed ID: 31801039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.